Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Net Margin (2016 - 2024)

Historic Net Margin for Arcadia Biosciences (RKDA) over the last 11 years, with Q4 2024 value amounting to 2.22%.

  • Arcadia Biosciences' Net Margin rose 2771900.0% to 2.22% in Q4 2024 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 1051000.0%. This contributed to the annual value of 53.93% for FY2024, which is 1220000.0% up from last year.
  • As of Q4 2024, Arcadia Biosciences' Net Margin stood at 2.22%, which was up 2771900.0% from 27.98% recorded in Q3 2024.
  • Over the past 5 years, Arcadia Biosciences' Net Margin peaked at 817.15% during Q1 2020, and registered a low of 3448.04% during Q2 2020.
  • Moreover, its 5-year median value for Net Margin was 118.9% (2022), whereas its average is 330.41%.
  • Within the past 5 years, the most significant YoY rise in Arcadia Biosciences' Net Margin was 87994300bps (2020), while the steepest drop was -55352300bps (2020).
  • Arcadia Biosciences' Net Margin (Quarter) stood at 131.46% in 2020, then tumbled by -344bps to 320.98% in 2021, then surged by 106bps to 19.75% in 2022, then tumbled by -1515bps to 279.41% in 2023, then soared by 99bps to 2.22% in 2024.
  • Its Net Margin was 2.22% in Q4 2024, compared to 27.98% in Q3 2024 and 60.41% in Q2 2024.